Arecor Therapeutics PLC Sustainability Reports
Arecor Therapeutics PLC is a clinical-stage biopharmaceutical company leveraging its proprietary formulation technology platform, Arestat, to develop superior therapeutic products. Its primary focus is on expanding and enhancing treatments for diabetes, obesity, and other cardiometabolic diseases.
Sector: Manufacturing
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
LEI: 98450093D12I3A8DDD58
FIGI: BBG011354DT7
5 reports from 2021 to 2025
